Public buyer answers
What the website offers, what data you can share and what to confirm before customer use.
Read the answers →Tenvia Trust Centre
Tenvia connects protocol design, evidence, team review and decision history. Accountable specialists make the study decisions. Explore the security, data use and commercial arrangements for your team.
Direct answers
Document availability · Reviewed 1 October 2026
Open the public resources below. The other entries show documents whose availability still needs confirmation. We only describe a document as available under a confidentiality agreement when we have confirmed that it exists and can be shared.
What the website offers, what data you can share and what to confirm before customer use.
Read the answers →A guide to planning your checks. It does not prove that the listed safeguards are in place.
Open the checklist →A blank worksheet for a fair comparison of quality, time and unresolved questions.
Open the scorecard →Fictional RD-204 review; not a customer export or validated audit record.
Inspect the record →An approved provider list for a customer service is not published. Ask where data goes, who can access it, how long it is kept and whether it is used for AI training.
Request availability →Public principles are available; the existence, date, scope and disclosure conditions of assessment reports need confirmation.
Request availability →Ask what the product is intended for, its version, test results, known limits and the responsibilities of Tenvia and your team.
Request availability →The website describes the contracting path. Approved agreement versions, legal entities, pricing and service commitments are not published.
Request availability →Support levels, recovery times and incident-reporting commitments are not published here. Obtain these terms before customer use.
Request availability →This buyer pack does not include customer case studies or measured clinical performance results. Public demonstrations use fictional data.
Request availability →The review date refers to this list, not to an audit. For any report, check who issued it, what it covers, its date, relevant product version, limits and sharing conditions.
Your protocol and your data
These are the steps to agree before an evaluation. They are a planning guide, not a confirmed description of a live customer service.
Define permitted documents, users and data handling before sharing a protocol.
Review extracted information against its source. Confirm, correct or reject it.
Check permitted sources, relevance, dates and gaps alongside the design question.
Agree model providers, permitted inputs and data routes. Check suggestions and their limitations.
Responsible specialists examine the proposal. The team records the decision and its reasoning.
Agree version history, access, export, retention and deletion for the engagement.
The planned workflow uses registered and permitted sources such as public registries, accessible protocols, amendments and literature where source-specific access is qualified. ClinicalTrials.gov and AACT copies of one NCT study must retain their source history and must not count twice. The website comparison uses 42 fictional studies, not a live dataset. No named-source operational access is promised here.
A released comparison must show study identities, filters, match criteria, method/version, denominator, source snapshot and retrieval dates, exclusions, missingness and applicability limits. Historical similarity does not establish clinical appropriateness, statistical adequacy or recruitment feasibility.
Planned intake retains the original document/version and page or section beside the fact, extraction limits, AI proposal and attributable human correction. A confirmed draft is not an approved protocol version. Verify this behaviour for the exact evaluated release.
The required model separates public evidence from sponsor-private documents and derived results. Organisation, study, object, field, blinding and disclosure permissions must apply to retrieval, summaries, exports and caches. A CRO working for multiple sponsors has no pooling rights by default. Deployment evidence must prove these boundaries before confidential use.
Missing evidence, unreadable material, stale reviews and unassessed dependencies must remain explicit. Do not infer a reassuring score or agreement from silence. The intended record preserves dissent, role-specific consequences, responses and the human disposition against the exact version.
Planned outputs pin the study/baseline, template, mapping/method and source/decision versions. A change identifies affected artifacts and prepares new drafts for review. Earlier approved artifacts remain intact; generation, export, sharing and release are separate permissions.
Each future route must qualify the exact approved study, destination product/version/environment, mapping, permissions, compatibility tests and semantic read-back. Partial results or uncertain acknowledgements are unresolved, not successful. An assisted non-production Rave ALS draft-import route is planned; no live or universal EDC connector is promised.
Request a diagram showing where your data goes and a list of the AI providers for your service. The proposed system includes a gateway to control access to AI models. Ask for evidence that it works and protects data in the service you will use.
Explore AI and model governance →Review by topic
Security, privacy and data governance, AI, clinical quality and procurement each have their own questions and evidence list.
Security & supplier review
Explore the product, discuss a study or request assurance evidence. Choose the conversation your team needs.
Tell us which security, privacy, quality or architecture evidence your team needs to review.
Please keep patient information and confidential study documents out of this request.
Submit your enquiry directly through HubSpot.
Tenvia will contact you to follow up.
Prefer a direct conversation?